title: Tilt testing with combined lower body negative pressure: a "gold standard" for measuring orthostatic tolerance.
abstract: Orthostatic tolerance (OT) refers to the ability to maintain cardiovascular stability when upright, against the hydrostatic effects of gravity, and hence to maintain cerebral perfusion and prevent syncope (fainting). Various techniques are available to assess OT and the effects of gravitational stress upon the circulation, typically by reproducing a presyncopal event (near-fainting episode) in a controlled laboratory environment. The time and/or degree of stress required to provoke this response provides the measure of OT. Any technique used to determine OT should: enable distinction between patients with orthostatic intolerance (of various causes) and asymptomatic control subjects; be highly reproducible, enabling evaluation of therapeutic interventions; avoid invasive procedures, which are known to impair OT(1). In the late 1980s head-upright tilt testing was first utilized for diagnosing syncope(2). Since then it has been used to assess OT in patients with syncope of unknown cause, as well as in healthy subjects to study postural cardiovascular reflexes(2-6). Tilting protocols comprise three categories: passive tilt; passive tilt accompanied by pharmacological provocation; and passive tilt with combined lower body negative pressure (LBNP). However, the effects of tilt testing (and other orthostatic stress testing modalities) are often poorly reproducible, with low sensitivity and specificity to diagnose orthostatic intolerance(7). Typically, a passive tilt includes 20-60 min of orthostatic stress continued until the onset of presyncope in patients(2-6). However, the main drawback of this procedure is its inability to invoke presyncope in all individuals undergoing the test, and corresponding low sensitivity(8,9). Thus, different methods were explored to increase the orthostatic stress and improve sensitivity. Pharmacological provocation has been used to increase the orthostatic challenge, for example using isoprenaline(4,7,10,11) or sublingual nitrate(12,13). However, the main drawback of these approaches are increases in sensitivity at the cost of unacceptable decreases in specificity(10,14), with a high positive response rate immediately after administration(15). Furthermore, invasive procedures associated with some pharmacological provocations greatly increase the false positive rate(1). Another approach is to combine passive tilt testing with LBNP, providing a stronger orthostatic stress without invasive procedures or drug side-effects, using the technique pioneered by Professor Roger Hainsworth in the 1990s(16-18). This approach provokes presyncope in almost all subjects (allowing for symptom recognition in patients with syncope), while discriminating between patients with syncope and healthy controls, with a specificity of 92%, sensitivity of 85%, and repeatability of 1.1±0.6 min(16,17). This allows not only diagnosis and pathophysiological assessment(19-22), but also the evaluation of treatments for orthostatic intolerance due to its high repeatability(23-30). For these reasons, we argue this should be the "gold standard" for orthostatic stress testing, and accordingly this will be the method described in this paper.
authors.affiliation: Department of Biomedical Physiology and Kinesiology, Simon Fraser University.
authors.forename: Clare L
authors.initials: CL
authors.lastname: Protheroe
authors.forename: Henrike Rianne J C
authors.initials: HR
authors.lastname: Ravensbergen
authors.forename: Jessica A
authors.initials: JA
authors.lastname: Inskip
authors.forename: Victoria E
authors.initials: VE
authors.lastname: Claydon
mesh_terms: D001794:Blood Pressure / Q000502:physiology; D002245:Carbon Dioxide / Q000378:metabolism; D004562:Electrocardiography / Q000379:methods; D005260:Female; D006801:Humans; D054971:Orthostatic Intolerance / Q000175:diagnosis* / Q000503:physiopathology*; D010100:Oxygen / Q000378:metabolism; D010313:Partial Pressure; D013575:Syncope / Q000175:diagnosis / Q000503:physiopathology; D018667:Tilt-Table Test / Q000295:instrumentation* / Q000379:methods*
chemical_list: D002245:Carbon Dioxide; D010100:Oxygen
references.citation: Am J Physiol Heart Circ Physiol. 2009 Jul;297(1):H53-8
references.pmid: 19448145
references.citation: Yonsei Med J. 2010 Jan;51(1):77-81
references.pmid: 20046517
references.citation: PLoS One. 2011;6(12):e28193
references.pmid: 22194814
references.citation: Nat Rev Neurol. 2011 Dec 06;8(1):22-34
references.pmid: 22143364
references.citation: Ann N Y Acad Sci. 2001 Jun;940:514-26
references.pmid: 11458706
references.citation: Eur J Appl Physiol. 2005 Jul;94(4):408-14
references.pmid: 15843958
references.citation: Clin Auton Res. 2003 Dec;13(6):453-5
references.pmid: 14673698
references.citation: Clin Auton Res. 1994 Oct;4(5):233-7
references.pmid: 7888741
references.citation: Am J Cardiol. 1999 Sep 15;84(6):665-70
references.pmid: 10498136
references.citation: Clin Sci (Lond). 1989 Nov;77(5):547-53
references.pmid: 2582726
references.citation: Am Heart J. 1998 Apr;135(4):564-70
references.pmid: 9539468
references.citation: Heart. 1996 Feb;75(2):134-40
references.pmid: 8673750
references.citation: Am J Physiol Regul Integr Comp Physiol. 2006 Nov;291(5):R1443-8
references.pmid: 16763078
references.citation: J Am Coll Cardiol. 1993 Jul;22(1):114-8
references.pmid: 8509530
references.citation: Clin Auton Res. 2000 Oct;10(5):279-84
references.pmid: 11198483
references.citation: Clin Auton Res. 2003 Dec;13(6):403-5
references.pmid: 14673689
references.citation: Clin Sci (Lond). 1996 Aug;91(2):193-200
references.pmid: 8795443
references.citation: Am J Cardiol. 1966 Feb;17(2):211-8
references.pmid: 5323200
references.citation: Am J Med. 1995 Dec;99(6):689-90
references.pmid: 7503096
references.citation: Pacing Clin Electrophysiol. 2000 Dec;23(12):2138-40
references.pmid: 11202262
references.citation: Ann Neurol. 2008 Mar;63(3):288-94
references.pmid: 17823939
references.citation: Blood Press Monit. 2003 Feb;8(1):27-30
references.pmid: 12604933
references.citation: Spinal Cord. 2011 Feb;49(2):251-6
references.pmid: 20714335
references.citation: Clin Auton Res. 2008 Dec;18(6):318-24
references.pmid: 19015909
references.citation: Clin Auton Res. 2000 Apr;10(2):57-61
references.pmid: 10823336
references.citation: Stroke. 2000 Jul;31(7):1672-8
references.pmid: 10884472
references.citation: Clin Auton Res. 2007 Feb;17(1):26-32
references.pmid: 17264980
references.citation: Clin Auton Res. 2002 Aug;12(4):236-41
references.pmid: 12357276
references.citation: Clin Auton Res. 2004 Jun;14(3):176-81
references.pmid: 15241646
references.citation: Ann Intern Med. 1992 Mar 1;116(5):358-63
references.pmid: 1736767
references.citation: Heart. 1998 Dec;80(6):596-600
references.pmid: 10065030
references.citation: Clin Auton Res. 2003 Oct;13(5):321-9
references.pmid: 14564654
references.citation: J Am Coll Cardiol. 1996 Jul;28(1):263-75
references.pmid: 8752825
references.citation: Clin Auton Res. 2011 Apr;21(2):69-72
references.pmid: 21431947
references.citation: Am J Med. 1991 Jan;90(1):6-10
references.pmid: 1670907
references.citation: Am Heart J. 1992 Feb;123(2):538-41
references.pmid: 1736598
references.citation: J Cardiovasc Electrophysiol. 2003 Sep;14(9):920-4
references.pmid: 12950533
references.citation: Am J Med. 1994 Jul;97(1):78-88
references.pmid: 8030660
references.citation: Eur Heart J. 2009 Nov;30(21):2631-71
references.pmid: 19713422
references.citation: Circulation. 2002 Sep 24;106(13):1684-9
references.pmid: 12270863
references.citation: Europace. 2000 Jan;2(1):66-76
references.pmid: 11225598
references.citation: Clin Auton Res. 1991 Mar;1(1):43-53
references.pmid: 1821665
references.citation: Europace. 2001 Oct;3(4):261-8
references.pmid: 11678382
references.citation: Europace. 2003 Jul;5(3):303
references.pmid: 12842648
references.citation: Clin Auton Res. 1994 Oct;4(5):239-44
references.pmid: 7888742
references.citation: Clin Sci (Lond). 1999 Sep;97(3):291-301
references.pmid: 10464054
references.citation: Clin Auton Res. 1999 Apr;9(2):69-73
references.pmid: 10225610
references.citation: Cardiovasc Res. 1998 Jun;38(3):605-16
references.pmid: 9747429
references.citation: Arch Phys Med Rehabil. 2010 Dec;91(12):1930-5
references.pmid: 21112436
references.citation: Clin Sci (Lond). 2006 Mar;110(3):343-52
references.pmid: 16321141
references.citation: Clin Sci (Lond). 1995 Apr;88(4):463-70
references.pmid: 7789049
references.citation: J Pediatr. 2012 Feb;160(2):222-6
references.pmid: 21996154
references.citation: Exp Physiol. 2004 Sep;89(5):565-71
references.pmid: 15184355
references.citation: Hypertension. 2004 Apr;43(4):809-13
references.pmid: 14981050
references.citation: PLoS One. 2011;6(10):e26489
references.pmid: 22046292
references.citation: Eur Heart J. 2001 Aug;22(15):1256-306
references.pmid: 11465961
references.citation: Clin Auton Res. 1994 Apr;4(1-2):41-7
references.pmid: 8054836